Life Science Company News

Results 421 - 440 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21 22  23  24  25 »

Exact Sciences Presents Data Showing Improved Accuracy of Second-generation Cologuard® Test and Progress Toward an Even Better Colorectal Cancer Screening Solution for Patients

Data Presented Include Prospective and Case-collected Samples and Show Improved Specificity of 92%, High Sensitivity for Colorectal Cancer at 95%, and Precancerous Lesion Sensitivity of 57%;Data Presented at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI);Exact... Read more ››
By: PR Newswire Association LLC. - 18 Jan 2022

Synergy Orthopedics & Dr. Tal S. David Announce Partnership with San Diego Legion Rugby Team for 2022 MLR Season

Read more ››
By: PR Newswire Association LLC. - 18 Jan 2022

What Do Christie Brinkley and Bono Have in Common?

A regular eye screening saved both from significant vision loss due to glaucoma Read more ››
By: PR Newswire Association LLC. - 18 Jan 2022

Global Filgrastim Market (2021 to 2027) - by Drug Type, Indication, Distribution Channel and Region

Read more ››
By: PR Newswire Association LLC. - 18 Jan 2022

Global Medical Copper Tubing Market Research Report (2021 to 2027) - by Type, Application, End-user and Region

Read more ››
By: PR Newswire Association LLC. - 18 Jan 2022

Global Inflammatory Bowel Disease Treatment Market (2021 to 2027) - by Type, Distribution Channel, Route of Administration, Drug Class and Region

Read more ››
By: PR Newswire Association LLC. - 18 Jan 2022

Canadian Pharmacists Association National Call to Action in Support of Pharmacy Professionals

Read more ››
By: PR Newswire Association LLC. - 18 Jan 2022

Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: PR Newswire Association LLC. - 18 Jan 2022

Syneos Health Appoints Two New Independent Directors

Read more ››
By: GlobenewsWire - 18 Jan 2022

NRx Pharmaceuticals Announces Expansion of ZYESAMI® (aviptadil) US Expanded Access and Right to Try Programs for Patients with COVID-19 Respiratory Failure who have Exhausted All Approved Treatments

Read more ››
By: GlobenewsWire - 18 Jan 2022

RVL Pharmaceuticals to Host UPNEEQ® Overview and Business Update Webcast on January 19, 2022

Read more ››
By: GlobenewsWire - 18 Jan 2022

Immuneering Strengthens Board of Directors with the Appointment of Diana F. Hausman, M.D.

Read more ››
By: GlobenewsWire - 18 Jan 2022

23andMe Announces Extension of GSK Collaboration and Update on Joint Immuno-oncology Program

Read more ››
By: GlobenewsWire - 18 Jan 2022

Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform

Read more ››
By: GlobenewsWire - 18 Jan 2022

HOOKIPA Announces First Patient Enrolled in Phase 2 Trial Evaluating HB-200 and Pembrolizumab for Treatment of Head and Neck Cancer and Reports FDA’s Fast Track Designation

Read more ››
By: GlobenewsWire - 18 Jan 2022

Surgalign Receives FDA Clearance for HOLO Portal™ System, the World’s First AI-driven AR Guidance System for Spine Surgery and Reports Preliminary Fourth Quarter and Full Year 2021 Results

Read more ››
By: GlobenewsWire - 18 Jan 2022

Eliem Therapeutics Provides Program Updates and an Overview of Expected Near-Term Milestones

Read more ››
By: GlobenewsWire - 18 Jan 2022

The Alliance for Advancing Bioelectronic Medicine Launches the First Bioelectronic Medicine Day

Read more ››
By: GlobenewsWire - 18 Jan 2022

ProMIS Neurosciences Announces Antibody Program for Schizophrenia Therapy and Recruitment of Dr. Carsten Korth to its Scientific Advisory Board

Read more ››
By: GlobenewsWire - 18 Jan 2022

Krystal Biotech Appoints Jing Marantz, MD, PhD, MBA as Chief Business Officer and Rand Sutherland, MD, MPH to its Board of Directors

Read more ››
By: GlobenewsWire - 18 Jan 2022
Results 421 - 440 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21 22  23  24  25 »

Enhance your business development with Biotechgate